Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...
BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...
GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer and UCB. The departures coincided with ...
"AOC removing the pronouns from her bio is a hell of a vibe shift," one social media user posted. X's community notes, ...
The company ended the quarter with $192 million in cash and equivalents, enough to fund operations past 2027. 2seventy Bio ...
MEMS, wearable/implantable electronics and bio-tissue therapeutics, the pursuit of piezoelectric biomaterials has become a ...
The clinical stage biopharmaceutical company is developing inhaled drug delivery devices. Transpire Bio expands headquarters ...
The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending ...
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) this week reported its third quarter financial results for 2024, ...
Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is ...
The European Commission is asking biopharma and manufacturing companies about their reaction to Novo ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback